Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-1.890%
-0.138
-1.890%
-
 
09:32 / Stuttgart Stock Exchange WKN: A2PF3G / Name: CorMedix / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock CorMedix Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for CorMedix

sharewise wants to provide you with the best news and tools for CorMedix, so we directly link to the best financial data sources.

News

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms
CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms

Key Points

CorMedix Q1 Earnings Call Highlights
CorMedix Q1 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported sharply higher first-quarter 2026 revenue and profit, driven by continued adoption of DefenCath and the

High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026
High Risk, High Reward: 3 Healthcare Stocks to Watch in 2026

Last year, the biotechnology industry leaned heavily into the power of artificial intelligence (AI), using machine learning models to identify drug targets, to optimize molecules, and to make key